MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
The Lancet Diabetes & Endocrinology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

247 results · 1 filter active ·
Results by year
20132025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
247 works in the cohort · of 4,299,418page 4 of 5

Labels cover 3 of 247 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 247 of 247 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Risks and benefits of childhood physical activity
Patricia E. Longmuir, Rachel C. Colley, Valerie Wherley, Mark S. Tremblay
2014· letter· en· The Lancet Diabetes & Endocrinology· Medicine
machine prediction:candidate · noneconsensus · none
22
citations
affno abstractunlabeled
Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial
Ronnie Aronson, Aihua Li, Ruth E. Brown, Sarah McGaugh, Michael C. Riddell
2020· article· en· The Lancet Diabetes & Endocrinology· Medicine
machine prediction:candidate · noneconsensus · none
22
citations
afffundno abstractunlabeled
Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial
Melanie J. Davies, Peter van der Meer, Subodh Verma, Shachi Patel, Khaja Chinnakondepalli, Barry A Borlaug +10 more
2025· article· en· The Lancet Diabetes & Endocrinology· Medicine
machine prediction:candidate · noneconsensus · none
19
citations
affno abstractunlabeled
Myostatin inhibition for treatment of sarcopenia
Gianni Parise, Tim Snijders
2015· letter· en· The Lancet Diabetes & Endocrinology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
15
citations
afffundno abstractunlabeled
Dulaglutide and renal protection in type 2 diabetes
David Z.I. Cherney, Subodh Verma, John D. Parker
2018· letter· en· The Lancet Diabetes & Endocrinology· Medicine
machine prediction:candidate · noneconsensus · none
14
citations
affno abstractunlabeled
Understanding EMPA-REG OUTCOME
Richard E. Gilbert, Kim A. Connelly
2015· letter· en· The Lancet Diabetes & Endocrinology· Medicine
machine prediction:candidate · noneconsensus · none
12
citations
affno abstractunlabeled
LDL cholesterol: lower, faster, younger?
Amanda J. Berberich, Robert A. Hegele
2019· letter· en· The Lancet Diabetes & Endocrinology· Medicine
machine prediction:candidate · noneconsensus · none
7
citations
affno abstractunlabeled
Intensive periodontal therapy and type 2 diabetes
Jean‐Noël Vergnes, Thibault Canceill, Paul Monsarrat
2019· letter· en· The Lancet Diabetes & Endocrinology· Dentistry
machine prediction:candidate · noneconsensus · none
6
citations

How this was built: Screen · Findings · About